Volume 10, Number 9—September 2004
Dispatch
Yellow Fever Virus Infectivity for Bolivian Aedes aegypti Mosquitoes
Table 2
Ae. aegypti strain | Virus strain | No. mice infected/ No. exposed (%) | HI titer for 4 U of antigen |
||
---|---|---|---|---|---|
YFV | SLEV | WNV | |||
Santa Cruz- | CENETROP-322 | 1/5 (20)b | 0 | 0 | 0 |
0 | 0 | 0 | |||
320 | 0 | 0 | |||
0 | 0 | 0 | |||
0 | 0 | 0 | |||
REX-D | Jimenez | 4/5 (80)c | NT | NT | NT |
NT | NT | NT | |||
NT | NT | NT | |||
NT | NT | NT | |||
NT | NT | NT | |||
REX-D | Asibi | 3/5 (60)b | 160 | 0 | 0 |
0 | 0 | 0 | |||
0 | 0 | 0 | |||
80 | 0 | 0 | |||
40 | 0 | 0 |
aHI, hemagluttination-inhibition; YFV, yellow fever virus; SLEV, St. Louis encephalitis virus; WNV, West Nile virus; NT, not tested.
bInfection determined by presence of anti-YF antibodies in mice sera (HI test). 0 indicates a titer of <1:20.
cInfection determined by death/virus detection for suckling mice.
Page created: March 25, 2011
Page updated: March 25, 2011
Page reviewed: March 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.